{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0003-3631#drug","name":"REYATAZ","alternateName":"ATAZANAVIR","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0003-3631"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA021567"},{"@type":"PropertyValue","propertyID":"UNII","value":"4MT4VIE29P"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"165cff62-b284-4a27-a65d-9ec8a5bfcdd8"}],"activeIngredient":"ATAZANAVIR SULFATE","administrationRoute":["ORAL"],"dosageForm":"CAPSULE, GELATIN COATED","manufacturer":{"@type":"Organization","name":"E.R. Squibb & Sons, L.L.C."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA021567","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-3631"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T00:04:47.920Z"}}